Skip to main content
OpenTrials
Completed

NCT Number: NCT00513916

Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. Eating a diet high in isoflavones, compounds found in soy foods, may keep cancer from forming.

PURPOSE: This randomized phase III trial is studying the effects of dietary soy on estrogens in breast fluid, blood, and urine samples from healthy women.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Cancer Research Center of Hawaii

Honolulu, Hawaii, 96813, United States

About this study

OBJECTIVES:

  • Examine the effects of two daily servings of soy on estrogen levels in nipple aspirate fluid (NAF) and serum.
  • Investigate cytologic patterns of epithelial breast cells obtained from NAF as a measure of proliferation in relation to soy intake.
  • Explore the effect of two daily servings of soy on cytochrome alterations of estrogen metabolism as expressed in the formation of urinary 2-, 16α-, and 4-hydroxy estrogen metabolites.
  • Compare estrogen levels in NAF and serum measured at the same time during the luteal phase.

OUTLINE: This is a multicenter study. Participants are randomized to 1 of 2 intervention arms.

  • Arm I: Participants partake in a high soy diet consisting of 2 daily soy servings (approximately 50mg isoflavones). The choice of soy foods will include ½ cup of tofu, ¾ cup of soy milk, or ¼ cup of soy nuts. Replacement of currently consumed foods with soy foods will be encouraged.
  • Arm II: Participants will be asked to keep their soy intake below 3 servings per week. The participants will also receive general nutrition counseling.

In both arms, intervention continues for 6 months. After 6 months, participants undergo a 1-month washout period and then cross-over to the other intervention arm.

Nipple aspirate fluid, urine, and blood samples are collected periodically to measure laboratory endpoints.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

DISEASE CHARACTERISTICS:

  • Healthy participant
  • No diagnosis of cancer

PATIENT CHARACTERISTICS:

  • Premenopausal
  • Regular menstrual cycles

PRIOR CONCURRENT THERAPY:

  • Not taking birth control pills or other hormones

Treatment and study plan

Soy isoflavones

Dietary Supplement

High or low dose of soy isoflavones in the diet.

Primary outcomes

  1. Effect of two daily servings of soy on estrogen levels in nipple aspirate fluid (NAF) and serum

  2. Cytologic patterns of epithelial breast cells obtained from NAF

  3. Effect of two daily servings of soy on cytochrome alterations of estrogen metabolism as expressed in the formation of urinary 2-, 16α-, and 4-hydroxy estrogen metabolites

  4. Comparison of estrogen levels in NAF and serum measured at the same time during luteal phase

Sponsors and collaborators

Lead sponsor

University of Hawaii Cancer Research Center

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Effects of Soy on Estrogens in Breast Fluid and Urine

Important dates

Study start
2006
Primary completion
2011
Study completion
2012
First posted
Aug 9, 2007
Registry last updated
Dec 19, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.